Evidence map›Paper›PMID 27918527›Full record

ArticleNature microbiology2016

Induction and suppression of antiviral RNA interference by influenza A virus in mammalian cells.

Yang Li, Megha Basavappa, Jinfeng Lu, Shuwei Dong, D Alexander Cronkite, John T Prior, Hans-Christian Reinecker, Paul Hertzog, Yanhong Han, Wan-Xiang Li and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Targeting viral suppressor of RNAi confers anti-coronaviral activity.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  16. Getting the host antiviral machinery back on track: Targeting viral suppressors of RNA interference.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Yang LiDepartment of Plant Pathology &Microbiology, and Institute for Integrative Genome Biology, University of California, Riverside, California 92521, USA.
Megha BasavappaGastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Jinfeng LuDepartment of Plant Pathology &Microbiology, and Institute for Integrative Genome Biology, University of California, Riverside, California 92521, USA.
Shuwei DongDepartment of Plant Pathology &Microbiology, and Institute for Integrative Genome Biology, University of California, Riverside, California 92521, USA.
D Alexander CronkiteGastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
John T PriorGastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Hans-Christian ReineckerGastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Paul HertzogCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, Victoria 3168, Australia.
Yanhong HanDepartment of Plant Pathology &Microbiology, and Institute for Integrative Genome Biology, University of California, Riverside, California 92521, USA.
Wan-Xiang LiDepartment of Plant Pathology &Microbiology, and Institute for Integrative Genome Biology, University of California, Riverside, California 92521, USA.
Sihem CheloufiMassachusetts General Hospital, Cancer Center and Center for Regenerative Medicine and Harvard Stem Cell Institute, 185 Cambridge Street, Boston, Massachusetts 02114, USA.
Fedor V KarginovDepartment of Cell Biology and Neuroscience, University of California, Riverside, California 92521, USA.
Shou-Wei DingDepartment of Plant Pathology &Microbiology, and Institute for Integrative Genome Biology, University of California, Riverside, California 92521, USA.
Kate L JeffreyGastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
University of California, Riverside · USHarvard University · USMassachusetts General Hospital · USInstitut thématique Génétique, génomique et bioinformatique · FRFudan University · CNHudson Institute of Medical Research · AU

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Gene Silencing as an Antiviral Defense in Animal CellsR01AI052447 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI DING, SHOU-WEI · 2003 to 2016
$6.0M
Innate Immune Defense Mechanisms in the IntestineR01AI113333 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI REINECKER, HANS-CHRISTIAN · 2014 to 2025
$5.7M
Antigen Recognition at Intestinal Epithelial InterphasesR01DK068181 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI REINECKER, HANS-CHRISTIAN · 2005 to 2017
$5.2M
Argonaute proteins in the mammalian antiviral responseR01AI107087 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI JEFFREY, KATE LOUISA · 2014 to 2018
$2.2M
Inducible Regulatory B cells IBREGR01AI081807 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI REINECKER, HANS-CHRISTIAN · 2011 to 2015
$1.9M
IL-22 pathway in IBDR01DK091247 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI REINECKER, HANS-CHRISTIAN · 2013 to 2016
$1.4M
Antiviral immunity directed by virus-derived small silencing RNAs in miceR56AI110579 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI DING, SHOU-WEI · 2015 to 2015
$372k
NIAID NIH HHS R01 AI052447NIAID NIH HHS R01 AI081807NIAID NIH HHS R01 AI107087NIAID NIH HHS R01 AI113333NIAID NIH HHS R56 AI110579NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK068181NIDDK NIH HHS R01 DK091247
6 · The paper itself

Abstract

Influenza A virus (IAV) causes annual epidemics and occasional pandemics, and is one of the best-characterized human RNA viral pathogens

Indexed as

Host-Pathogen InteractionsRNA InterferenceAnimalsArgonaute ProteinsCell LineChromatin ImmunoprecipitationHumansInfluenza A virusProtein BindingRNA, ViralViral Nonstructural ProteinsArgonaute ProteinsINS1 protein, influenza virusRNA, ViralViral Nonstructural Proteins

Identifiers

PMID27918527
PMCPMC5488270
OpenAlexW2559907051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.